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An in vitro reconstitution system for the analysis of replication-
coupled nucleosome assembly is described. In this ‘‘two-step sys-
tem,’’ nucleosome assembly is performed in a separate reaction
from DNA replication, wherein purified newly replicated DNA
remains noncovalently marked for subsequent chromatin assem-
bly factor-1 (CAF-1)-dependent nucleosome assembly. Because the
nucleosome assembly is performed separately from the DNA rep-
lication step, this system is more versatile and biochemically
tractable when compared with nucleosome assembly during sim-
ian virus 40 (SV40) DNA replication. The N-terminal domains of
histones H3 and H4 play an important but redundant function in
nucleosome assembly in the budding yeast, Saccharomyces cerevi-
siae. It had been proposed that at least one tail of histone H3 or H4
is required for replication-coupled nucleosome assembly. How-
ever, we demonstrate that the N-terminal domains of both histone
H3 and H4 are dispensable for CAF-1-mediated formation of
nucleosome cores onto newly replicated DNA in vitro. CAF-1 and
each of its individual subunits stably bound to recombinant
(H3.H4)2 tetramers lacking the N-terminal domains of both H3 and
H4. Therefore, the N-terminal tails of histone H3 and H4 that
contain the specific acetylation sites are not necessary for CAF-1-
dependent nucleosome assembly onto replicated DNA. We suggest
that the histone acetylation may be required for a CAF-1 indepen-
dent pathway or function after deposition, by marking of newly
replicated chromatin.
In S phase, preexisting chromatin structures are transientlydisrupted, providing a window of opportunity for reprogram-
ming gene expression. Therefore, mechanisms must exist to
ensure that differences between cell types are maintained
through DNA replication (1). During DNA replication, preex-
isting nucleosomes are segregated randomly onto the two prog-
eny DNA molecules (2). Additional nucleosomes are formed
from newly synthesized histone (H3.H4)2 tetramers, which sub-
sequently associate with either preexisting or newly synthesized
H2A.H2B dimers to form nucleosome cores (3, 4). The nucleo-
some cores are then organized into uniformly spaced arrays, a
reaction that requires ATP hydrolysis and, in vitro, can be
catalysed by a number of distinct proteins (5–7). The incorpo-
ration of histone H1 stabilizes the formation of higher-order
structures in mature chromatin (8, 9).
De novo nucleosome formation onto nascent DNA in a human
cell-free system for simian virus 40 (SV40) DNA replication
requires chromatin assembly factor 1 (CAF-1). The CAF-1
protein consists of three polypeptide subunits: p150, p60, and
p48 (10, 11). In human cells, CAF-1 acts as a core histone
chaperone by forming a stable complex with newly synthesized
histones H3 and H4 (10, 11), and targeting these histones to sites
of DNA synthesis (12, 13). This preferential assembly of
(H3.H4)2 tetramers onto replicating DNA is, at least in part,
because of an interaction between CAF-1 and the proliferating
cell nuclear antigen (PCNA) (14), an essential DNA polymerase
processivity factor.
The histones associated with CAF-1 in human cells exhibit a
heterogeneous pattern of posttranslational modification (11).
Histone H4 is a mixture of molecules containing zero, one, two,
or three acetyl groups at lysines 5, 8, or 12. Although histone H3
is also modified, the nature of this modification has not yet been
determined. Interestingly, diacetylation of lysines 5 and 12 of H4
and acetylation of various residues of H3 have been observed in
a number of different species (15). In addition, a dedicated
enzyme that specifically acetylates lysines 5 and 12 of newly
synthesized H4 before its incorporation into chromatin has been
identified in a number of evolutionarily divergent organisms
(16–18). The importance of either the N-terminal domain or
these histone modifications for nucleosome assembly during
S-phase has emerged from elegant molecular genetic experi-
ments in Saccharomyces cerevisiae. Haploid yeast strains con-
taining either truncated H3.H4 N-termini, or the triple point
mutation K5G K8G K12G in H4 and an N-terminal deletion of
H3, exhibited a defect in nucleosome assembly and accumulated
nonviable cells arrested in G2 with a ’3 N DNA content (19, 20).
Thus, although redundant with each other, the N-terminal
domains of H3 and H4 collectively play an essential role in
maintaining cell viability, presumably through their site-specific
acetylation. However, the precise biochemical function of the
site-specific acetylation of newly synthesized H3 and H4 is
currently unknown.
The human cell-free system for nucleosome assembly during
SV40 DNA replication has proven particularly useful to identify
CAF-1. However, its use for further analysis of replication-
coupled nucleosome assembly has been limited. To overcome
these limitations, we took advantage of the fact that newly
replicated DNA remains marked as a preferential substrate for
CAF-1-mediated nucleosome assembly (14). Here, this ‘‘two-
step’’ system is described in detail and it is used to demonstrate
that the N-terminal domains of both H3 and H4 were dispens-
able for preferential assembly of histones onto replicated DNA
by CAF-1.
Materials and Methods
Purified Proteins and Antibodies. SV40 T antigen and DNA topo-
isomerases I and II were prepared as described previously (14).
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Recombinant human CAF-1, a complex of p150yp60, p150, and
p60 were purified from baculovirus-infected Sf9 insect cells as
described (10). The CAF-1 p60 (SS24) and p150 (SS1) mono-
clonal antibodies were described previously (21).
Affinity Purification of cH3.H4 and Preparation of H3yH4-Depleted
S100 Extract. Complexes containing newly synthesized and acety-
lated H3.H4 (cH3.H4) were partially purified from an extract
from human 293 cells (S100 extract) by incubation for 2 h at 4°C
with 1 ml of H4N antibody beads (22). The beads were washed
with buffer A100 and eluted at 37°C with 2 ml of buffer A1000
containing 70 mg H4N peptide per ml twice. The elutes were
pooled, dialyzed against buffer A50, and concentrated about
5-fold by dehydration in a bed of dry sucrose. H3 and H4 were
immunodepleted as described previously (11). Buffer A is 25
mM TriszHCl, pH 8.0, 10% glycerol, 1 mM Na2EDTA, 0.01%
Nonidet-P40, and the number following buffer A is the NaCl
concentration in millimolar. Each buffer also contained 5 mM
sodium butyrate, 1 mM DTT, and a mixture of protease inhib-
itors (0.1 mM PMSF, 0.1 mM Prefabloc, 1 mM benzamidinez
HCl, 1 mgyml pepstatin A, 1 mgyml leupeptin).
Preparation of Wild-Type and (H3.H4)2 Tetramers Lacking the N-
Terminal Domains of H3 andyor H4. Expression and purification of
wild-type or mutant histones lacking the N-terminal domains of
H3 andyor H4 was performed as described (23). H3DN lacked
amino acid residues 1–23 and contained an S28C amino acid
substitution introduced for x-ray crystallography; H4DN lacked
residues 1–16, residue 1 being the first residue following the
initiator methionine. Histone refolding and formation of
(H3.H4)2 tetramers was also performed as described (23). To
remove misfolded or monomeric H3 or H4 molecules, each
recombinant (H3.H4)2 tetramer was purified by gel filtration
through a Superdex-200 column in 2 M NaCl, 10 mM TriszHCl
(pH 7.5), 1 mM Na-EDTA, 5 mM 2-ME.
Nucleosome Assembly in Two-Step System. SV40 DNA replication
and semipurification of DNA by Miniprep Spun Column (Am-
ersham Pharmacia) is described previously (14). The effluent
(approximately 30 fmol of DNA as seen in Figs. 2 A and 3 A and
B, or 15 fmol of DNA as seen in Fig. 4B) was incubated with
CAF-1, S100, or S100(2) extract, affinity-purified cH3.H4 or
recombinant (H3.H4)2, and DNA topoisomerases I (13 ng) and
II (100 ng). Nucleosome assembly was performed for 40 min at
37°C, followed by an additional 15 min after addition of 400 ng
of histone H2A.H2B dimers purified from human 293 cell
chromatin (24). For supercoiling assays, DNA samples were
treated as described before (25).
Binding of CAF-1 to Recombinant (H3.H4)2 Tetramers. The indicated
amounts of purified (H3.H4)2 tetramers and recombinant
CAF-1, p150, p60, or p150yp60 were incubated for 2 h at 4°C in
buffer A400. After incubation with monoclonal antibody beads
for 2 h, the beads were washed five times with 600 ml of buffer
A400 per wash. Immunoprecipitated proteins were analyzed in
SDS-18% polyacrylamide histone gels (26) and analyzed either
by silver staining or Coomassie blue staining.
Glutathione S-Transferase (GST)-Histones and GST Pull-Down Assays.
Expression and purification of GST-fused histones in Escherichia
coli was performed as described (18, 27). Pull-down assays were
performed in 400 ml of buffer A300, with 100 pmol of recom-
binant p60 and ’5 mg of each GST-histone immobilized to
glutathione-Sepharose beads. After incubation for 2 h at 4°C,
beads were washed five times with 600 ml of buffer A300. The
amount of p60 remaining bound to beads was determined by
SDSyPAGE and immunoblotting.
Results
CAF-1 Assembles Nucleosomes onto Replicated DNA in a Rapid and
Stoichiometric Manner. In a recent study, we showed that fully
replicated DNA can be purified away from the bulk of free
proteins in the S100 extract used for SV40 DNA replication by
centrifugation through a gel filtration spin column. This purified
replicated DNA remained a good substrate for CAF-1-mediated
nucleosome assembly, whereas unreplicated DNA could not be
assembled into nucleosomes. This observation allowed us to
establish a two-step system for the analysis of replication-
coupled nucleosome assembly (14, 28). In this two-step system,
replication-coupled nucleosome assembly can be analyzed sep-
arately from DNA replication (Fig. 1). Although we do not know
whether nucleosome assembly in vivo occurs concomitantly with
the passage of replication fork or shortly after DNA synthesis,
the nucleosome assembly by CAF-1 seen in our two-step system
is clearly postreplicative. Indeed, no DNA synthesis was ob-
served during the nucleosome assembly reaction when labeled
dAMP was included in the assay (unpublished data, and ref. 14).
The amount of CAF-1 required for nucleosome assembly
during SV40 DNA replication was compared with the amount
necessary to achieve a similar level of nucleosome assembly onto
isolated newly replicated DNA in the two-step system. The
addition of identical amounts of CAF-1 changed the distribution
of the labeled DNA from relaxed circular DNA (form Io) to
supercoiled DNA (form I) to very similar extents in both
reactions (Fig. 2A and B). Interestingly, in both systems, just a
2-fold increase in CAF-1 concentration resulted in a dramatic
Fig. 1. Scheme of the two-step system for the analysis of replication-coupled
nucleosome assembly. Newly replicated DNA purified by spin-column chro-
matography is competent for replication-dependent nucleosome assembly by
CAF-1. In this vitro system, replication-dependent nucleosome assembly is
analyzed in a completely separate reaction from the DNA replication reaction.
The DNA replication products are first separated from the replication proteins,
and then a second nucleosome assembly reaction is performed. To allow
nucleosome assembly to proceed, the effluent from the spin column contain-
ing DNA is incubated with fresh S100 extract, CAF-1, and topoisomerase
activities for various periods of time, followed by additional incubation with
H2A.2B for 15 min. Because this is a reconstitution system, S100 extract can be
replaced by H3.H4-depleted S100 extract and recombinant H3.H4 tetramers in
some experiments (see Fig. 3B).








increase in supercoiled form I DNA as a result of nucleosome
formation (Fig. 2 A and B, lanes 3 and 4). Because approximately
7% of the input DNA was replicated, we estimated that about
one molecule of CAF-1 was necessary to form each nucleosome
either during SV40 DNA replication (Fig. 2B, lane 4) or during
their assembly onto replicated DNA (Fig. 2 A, lane 4). Although
this calculation was only an approximation, it clearly revealed
that CAF-1 did not function in a catalytic manner to promote
nucleosome formation in either of these assays.
Previous studies of the kinetics of nucleosome assembly during
SV40 DNA replication showed that the appearance of form I
DNA occurs after a lag of about 15–30 min (29). This corre-
sponds roughly to the time taken for completely replicated
circular DNA to appear in this system (30). A time course of
nucleosome formation after the addition of CAF-1 and S100
extract to purified replicated DNA revealed that extensively
supercoiled DNA (form I) was first observed between 5 and 10
min and was essentially complete after 15 min. The residual 5-
to 10-min delay seen before the appearance of form I DNA could
reflect either the time taken for the recruitment of CAF-1-
histone complexes to the replicated DNA, the time necessary for
the acquisition of nucleosome-constrained superhelical tension
or the topoisomerase-mediated relaxation of superhelical ten-
sion in the internucleosomal DNA.
CAF-1-Dependent Nucleosome Formation onto Replicated DNA from
Core Histone Tetramers Lacking N-Terminal Domains of Both H3 and
H4. In human cells, the bulk of the CAF-1 protein is associated
with acetylated H3yH4 (11) and molecular genetic experiments
in S. cerevisiae strongly argue that site-specific acetylation of
these histones is important for some aspect of nucleosome
assembly (20). We therefore sought to determine whether the
N-terminal domains of either H3 or H4 were essential for
CAF-1-mediated nucleosome assembly onto replicated DNA by
the two-step system. For this purpose, we purified core histone
tetramers, either with or without the N-terminal domain(s) of
H3 and H4, from recombinant histones expressed in E. coli (23).
Fig. 3A shows a Coomassie brilliant blue-stained SDS-
polyacrylamide gel containing equivalent amounts of each re-
combinant core (H3.H4)2 tetramer.
Both wild-type and mutant (H3.H4)2 tetramers lacking the
N-terminal domains of H3 andyor H4 were mixed with purified
Fig. 2. Biochemical analysis of CAF-1-dependent nucleosome assembly. (A)
Nucleosome assembly in the two-step system. Replicated and semipurified
DNA was subjected to supercoiling reactions with increasing amounts of
CAF-1 either in the presence or the absence of S100 (56 mg), as indicated. (B)
Nucleosome assembly during SV40 DNA replication. SV40 DNA replication
reactions were performed with a large SV40 T-antigen and S100 (87.5 mg) in
the presence of increasing amounts of CAF-1 for 45 min. (Upper) An autora-
diograph and (Lower) an ethidium bromide-stained gel showing bulk DNA.
Molar ratio between CAF-1 and total DNA (not replicated DNA) is indicated in
A and B. Migration of relaxed, covalently closed circular DNA (form Io), nicked
circular DNA (form II), and negatively supercoiled DNA (form I) are indicated.
Fig. 3. N termini of H3.H4 are not required for CAF-1-dependent nucleosome assembly. (A) A Coomassie blue-stained gel. Four different H3.H4 tetramers (40
or 160 pmol) were loaded on 18% polyacrylamide gel, and stained with Coomassie blue. (B) CAF-1-dependent nucleosome assembly with recombinant (H3.H4)2.
A large-scale SV40 DNA replication was performed with H3.H4-depleted human cell extract S100(2). After separation of DNA, supercoiling assay was performed
with CAF-1 (50 fmol), S100(2) (48 mg), and increasing amounts of each recombinant (H3.H4)2, as indicated by 1 or 2. However, each recombinant (H3.H4)2 was
preincubated at 4°C for 15 min with CAF-1, and subsequently with S100(2) at 37°C for 15 min. (Upper) An autoradiography and (Lower) an ethidium
bromide-stained gel. Migrations of form I, Io, or II DNA are indicated as in Fig. 1.
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CAF-1 to allow them to form complexes, and these complexes
were added to a nucleosome assembly reaction containing
replicated DNA and the H3yH4-depleted S100 extract [hereaf-
ter referred to as S100(2)]. As revealed by the lack of form I
DNA, no extensive nucleosome formation took place in the
absence of recombinant (H3.H4)2 tetramers (Fig. 3B, lane 3),
indicating that the S100(2) extract did not contain residual
histones H3yH4 in sufficient amounts to generate supercoiling
of the replicated DNA. However, CAF-1-dependent nucleosome
assembly, as monitored by preferential supercoiling of replicated
DNA, was restored on addition of increasing amounts of any four
distinct (H3.H4)2 tetramers (Fig. 3B, lanes 4–19). Importantly,
the degree of supercoiling obtained with the different forms of
the core histone tetramer, even (H3.H4)2 tetramers lacking the
N-terminal domains of both H3 and H4, was very similar. In
addition, the products obtained with either wild-type (H3.H4)2
tetramers or tetramers lacking the N-terminal domains of both
H3 and H4 also gave rise to short nucleosomal ladders (primarily
mono-, di-, and tri-nucleosomes) spaced by about 140 bp (data
not shown) on treatment with micrococcal nuclease. These
results demonstrated that the N-terminal domains of both H3
and H4 (including all of the known acetylation sites in H3 and
H4) were dispensable for CAF-1-dependent nucleosome assem-
bly onto replicated DNA.
The N-terminal Domains of H3 and H4 Are Not Required for Their
Interaction with CAF-1. The result shown in Fig. 3B suggested that
CAF-1 binding to (H3.H4)2 tetramers did not require the
presence of the N-terminal domains of either H3 or H4. To verify
that this was the case, either wild type or mutant (H3.H4)2
tetramers lacking the N-terminal domains were incubated in the
presence or absence of purified CAF-1. Histone binding to
CAF-1 was detected by immunoprecipitation of CAF-1 with a
monoclonal antibody against the p60 subunit. As shown in Fig.
4A, wild-type and mutant (H3.H4)2 tetramers were both pre-
cipitated by the CAF-1 p60 monoclonal antibody only in the
presence of CAF-1. Because this gel was stained with silver, the
H4 band is less prominent than the H3 band (Fig. 4A). This was
most likely an artifact of our silver staining protocol, as opposed
to reflecting a reduced efficiency of H4 precipitation relative
to H3.
In an independent approach, equimolar amounts of wild-type
and mutant (H3.H4)2 tetramers lacking the N-terminal domains
of both H3 and H4 were incubated in the presence or absence
of a substoichiometric amount of CAF-1 (1 mol CAF-1: 2 mol
tetramer). The complexes formed were immunoprecipitated
with monoclonal antibodies against two distinct subunits of the
CAF-1 protein. Fig. 4B shows that equal amounts of both
wild-type and mutant (H3.H4)2 tetramer were coprecipitated by
different CAF-1 monoclonal antibodies only in the presence of
CAF-1. Core histone tetramers were previously shown to be very
stable even at relatively low ionic strength in the absence of DNA
(31). Under the relatively mild conditions of our binding assays
(50 mM TriszHCl, pH 8.0, 400 mM NaCl), the original (H3.H4)2
tetramers were unlikely to dissociate into individual histones to
reform mixed tetramers lacking only the N-terminal domain of
either H3 or H4. Therefore, the result shown in Fig. 4B dem-
onstrated that, under the conditions of our in vitro competitive
binding assay, CAF-1 did not preferentially bind to tetramers
containing wild-type histones, even when the mutant tetramers
lacked the N-terminal domains of both H3 and H4.
In addition, trypsinized (H3.H4)2 tetramers, in which the
N-terminal domains of both H3 and H4 are digested, and CAF-1
cosedimented as a complex during glycerol gradient sedimen-
tation (data not shown). Thus, CAF-1 not only bound to
trypsinized (H3.H4)2, but also the complex formed was essen-
tially stable and static during glycerol gradient sedimentation at
near physiological ionic strength (25 mM TriszHCl, pH 8.0, 150
mM NaCl). We obtained similar results with either hyperacet-
ylated or hypoacetylated (H3.H4)2 tetramers purified from
human cells (data not shown).
All Three Subunits of CAF-1 Are Histone Binding Proteins. We have
argued that two acidic subunits of CAF-1, p150 and p48, have a
high affinity for histones (10, 11). However, p60, a subunit of
CAF-1 is also a histone binding protein. In Fig. 5A, recombinant
p60 was mixed with excess but equal amounts of GST-histones
and pulled down by glutathione beads. p60 was precipitated by
all GST-histones almost equally well, indicating that p60 has a
high affinity for four histones. This interaction is specific because
p60 is a neutral protein with calculated pI of 7.27, and GST-
RFC37 did not precipitate p60 at all.
In the competitive binding assay, the need for the N-terminal
domains of histones H3.H4 for the association with p150 and p60
was determined (Fig. 5B). Equimolar amounts of wild-type and
Fig. 4. N termini of H3.H4 are not required for association between CAF-1
and H3.H4. (A) Binding between histone H3.H4 and CAF-1. A total of 60 pmol
of either wild-type or mutant (H3.H4)2 tetramers was immunoprecipitated by
anti-p60 antibody either in the presence or the absence of recombinant CAF-1
(30 pmol), as indicated by 1 or 2. Precipitated proteins were loaded onto an
18% acrylamide gel, and analyzed by silver staining. (B) A competitive binding
assay. A total of 300 pmol of wild-type or mutant (H3.H4)2 tetramers were
immunoprecipitated by anti-CAF-1 antibodies (anti-p150 antibody for lanes 2
and 3 or anti-p60 antibody for lanes 4 and 5), either in the presence or the
absence of CAF-1 (150 pmol), as indicated by 1 or 2. Precipitated proteins
were analyzed in an 18% polyacrylamide gel and stained with Coomassie blue.
12.5% of input histones were loaded in lanes I. Three subunits of CAF-1 (p150,
p60, and p48), Ig heavy chain (IgH) and light chain (IgL), and each histone H3
and H4 are indicated.








mutant (H3.H4)2 tetramers lacking the N-terminal domains of
both H3 and H4 were incubated in the presence or absence of
a substoichiometric amount of p150, p60, or p150yp60. The
complexes formed were immunoprecipitated with monoclonal
antibodies against p150 or p60. Fig. 5B shows that p150, p60, and
p150yp60 complex could precipitate equal amounts of both
wild-type and mutant (H3.H4)2 tetramer. In a previous study, we
showed that p48 binds to helix 1 in the histone-fold domain of
H4, and binding of p48 to the helix 1 is largely independent of
the proximal region (residues 1–12), which contains the depo-
sition-related acetylation sites (18, 32). Here, we demonstrated
that p150 and p60 can bind to histones H3.H4, and the N-
terminal domains of H3 or H4 are not required for the binding.
CAF-1 was found to form a complex with newly synthesized
histones H3.H4 in living cells, but not with histones H2A.2B (11).
However, interestingly, CAF-1 can also bind to histone H2A.2B
in vitro and remains associated with H3.H4 on replicated DNA
even after the deposition of H3.H4, unlike other histone chap-
erones like NAP-1 (unpublished data). This observation suggests
that CAF-1 on DNA may play some additional role in formation
of chromatin than just assembly of histone H3.H4. We predict
that CAF-1 might be involved in the deposition of histone
H2A.2B dimmers to form a mature nucleosome, in a later
deposition-related histone deacetylation reaction, or in recruit-
ing of other chromatin components, like HP1 (33). Reconstitu-
tion of replication-coupled chromatin assembly with purified
factors by our two step system in vitro andyor structural analysis
of CAF-1 will contribute to further understanding of the mech-
anism of replication-coupled chromatin assembly.
Discussion
Previously, we showed that newly replicated DNA purified by
centrifugation through a gel filtration spin column was compe-
tent for CAF-1-mediated nucleosome assembly, and that PCNA,
a DNA polymerase clamp, functioned as a marker molecule for
CAF-1 (14). This suggested that PCNA was involved in chro-
matin assembly during DNA replication in vivo by recruiting
CAF-1 to the sites of DNA synthesis. In this report, we demon-
strated that assembly of nucleosomes onto the isolated replicated
DNA was facilitated by CAF-1 in a way similar to that seen
during SV40 DNA replication.
The two-step system for the analysis of replication-coupled
chromatin assembly presents two major advantages over the
previous system, where CAF-1 was added during SV40 DNA
replication. First, because the SV40 DNA replication step was
performed separately from the nucleosome assembly step, the
S100 extract could be readily fractionated to identify nucleosome
assembly factors. In the past, it was necessary to purify numerous
proteins required for reconstitution of SV40 DNA replication in
vitro (34), to begin fractionating the S100 extract to identify
nucleosome assembly factors. This approach was extremely
labor-intensive. We are currently isolating these potential as-
sembly factors using the two-step system. Our preliminary data
suggest that the recently identified RCAF (35) is an active
component in one of these fractions. Another advantage of the
two-step system is that it greatly facilitates immunodepletion
experiments. Indeed, the endogenous histone H3yH4 complexes
present in the S100 extract could be immunodepleted and
functionally replaced by complexes of CAF-1 and recombinant
(H3.H4)2 tetramers lacking the N-terminal domains of H3
andyor H4.
Although recombinant core histones expressed in E. coli are
not acetylated (36), they were rapidly acetylated during incuba-
tion at 37°C in the presence of the H3yH4-depleted S100(2)
extract (unpublished data). Therefore, the fact that (H3.H4)2
tetramers lacking the N-terminal domains of both H3 and H4
were as active as tetramers containing full-length histones
indicated that, once CAF-1 formed a stable complex with
(H3.H4)2 tetramers, the N-terminal domains of H3 and H4 (and,
by implication, their acetylation) were essentially dispensable for
nucleosome assembly onto replicated DNA. This result stands in
sharp contrast with the widespread view expressed in a number
of literature reviews (37–40) that CAF-1 only uses acetylated
(H3.H4)2 because it is bound to histones with a specific pattern
of acetylation in vivo. Furthermore, we demonstrated that
CAF-1 did not require the N-terminal domain of either H3 or H4
to bind to (H3.H4)2 tetramers in a complex.
We had reported previously that (H3.H4)2 tetramers isolated
from chromatin could not replace the acetylated histones present
in the S100 extract, because addition of chromatin-derived
H3yH4 resulted in supercoiling of both replicating and nonrep-
licating DNA in a CAF-1-independent manner (25, 30). How-
ever, the precise biochemical reason for this was not clear. In
retrospect, it seems likely that, under the low ionic strength
conditions required for SV40 DNA replication, the addition of
free, chromatin-derived (H3.H4)2 tetramers simply resulted in
their nonspecific binding to DNA, which occurred independently
of DNA replication. This interpretation is consistent with the
fact that, unlike chromatin-derived H3yH4, the histones H3yH4
present in the S100 extract are physically associated with non-
histone chromosomal proteins that decrease their nonspecific
affinity for DNA and prevent their binding to phosphocellulose
(25). In this paper, we effectively bypassed this problem by
Fig. 5. The N termini of H3.H4 are not required for association of p150 or p60
with H3.H4. (A) Binding of p60 to histones. A total of 50 pmol of recombinant
p60 was incubated with excess (’5 mg) GST-histones or GST-RFC (37-kDa
subunit of human RFC) and pulled down with glutathione beads. Precipitated
proteins were loaded on an 18% polyacrylamide gel and analyzed by Western
blotting with anti-p60 monoclonal antibody. 25% of input histones (I) were
loaded in lanes 1. (B) Competitive binding assay. A total of 50 pmol of
wild-type or mutant (H3.H4)2 tetramers were immunoprecipitated by anti-
CAF-1 antibodies (anti-p150 antibody for lanes 2, 3, 8, and 9 or anti-p60
antibody for lanes 5 and 6), either in the presence or absence of recombinant
p150, p150yp60 (25 pmol), or p60 (50 pmol), as indicated by 1 or 2. Precipi-
tated proteins were resolved in an 18% polyacrylamide gel and silver stained.
12.5% of input histones (I) were loaded in lane 1. p150, p60, and p48, Ig heavy
chain (IgH) and light chain (IgL), and individual histone H3 and H4 are
indicated.
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preforming complexes of CAF-1 and (H3.H4)2 tetramers, which
reduced the nonspecific affinity of H3yH4 for DNA. Although
the experiments described here do not rule out the possibility
that site-specific acetylation of either H3 or H4 may stimulate,
or even be required for de novo nucleosome assembly during
DNA replication in vivo, we propose that this histone acetylation
may function after assembly, such as marking newly replicated
chromatin.
A number of transcriptionally silent genes and heterochro-
matic loci are known to replicate late during S-phase (41). In
Schizosaccharomyces pombe, the functional integrity of hetero-
chromatin depends on maintenance of the histones in a generally
hypoacetylated state (42, 43). Thus, if the pool of newly synthe-
sized histones H3yH4 present in late S-phase tends to be
substantially less acetylated than those in early S-phase, their
assembly onto DNA by CAF-1 would ensure the maintenance of
hypoacetylated chromatin at late-replicating loci. However, it is
not yet clear whether the histones incorporated into nucleo-
somes during late S-phase are initially acetylated or not.
Furthermore, the ability of CAF-1 to promote assembly of
core histone tetramers into nucleosomes irrespective of their
state of acetylation could be physiologically relevant. CAF-1
mutants in S. cerevisiae show the mild UV sensitivity (44),
suggesting a potential role of CAF-1 in DNA replication-
independent and repair-associated nucleosome assembly in vivo.
This was confirmed by the recruitment of CAF-1 to sites of DNA
damage repair in UV-irradiated G1 or G2 human cells (13). In
S. cerevisiae, a cell-free system for DNA replication-independent
nucleosome assembly with extract outside S phase is inhibited by
H3yH4 posttranslational modification (45). Therefore, the abil-
ity of CAF-1 to promote nucleosome assembly of unacetylated
(H3.H4)2 tetramers, as reported here, may account for the
involvement of CAF-1 in nucleosome assembly outside S phase
in vivo.
Taken together, the data presented in this paper revealed that,
once core histone tetramers were bound to CAF-1, the N-
terminal domains of both H3 and H4 were essentially dispens-
able for nucleosome assembly onto replicated DNA. However,
importantly, the studies in yeast indicated the redundant roles in
nucleosome assembly of the site-specific acetylation of histone
H4 and the N-terminal domain of H3 (20). Null mutations in any
of the CAC genes encoding subunits of CAF-1 in S. cerevisiae
grow normally without significant loss of genome integrity (46).
This suggests the existence of at least one CAF-1-independent
pathway for replication-coupled nucleosome assembly. One
intriguing possibility is that some components of the CAF-1-
independent pathway have high affinity to specifically acetylated
nascent histones H3.H4 and facilitates their assembly onto newly
synthesized DNA preferentially. Further work is needed to
elucidate the biochemical function of the evolutionarily con-
served posttranslational acetylation of newly synthesized H3 and
H4 in nucleosome assembly.
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